Update on HER2 Testing in Breast Cancer: HER2-ultralow, HER2-low, HER2-null Clinical Categories and Challenges in HER2 Assessment
Journal of Clinical and Translational Pathology · 30.12.2026
DOI: 10.14218/jctp.2026.00040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Translational Pathology, online erschienen am 10.11.2026. Verfasst von Yan Hu und 5 weiteren Autor:innen. Die Arbeit nennt 87 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hu, Y., Tozbikian, G., Jones, D., Zhao, W., Parwani, A., & Li, Z. (2026). Update on HER2 Testing in Breast Cancer: HER2-ultralow, HER2-low, HER2-null Clinical Categories and Challenges in HER2 Assessment. Journal of Clinical and Translational Pathology. https://doi.org/10.14218/jctp.2026.00040
Vancouver
Hu Y, Tozbikian G, Jones D, Zhao W, Parwani A, Li Z. Update on HER2 Testing in Breast Cancer: HER2-ultralow, HER2-low, HER2-null Clinical Categories and Challenges in HER2 Assessment. Journal of Clinical and Translational Pathology. 2026. doi:10.14218/jctp.2026.00040
BibTeX
@article{Hu2026,
author = {Hu, Yan and Tozbikian, Gary and Jones, Daniel and Zhao, Weiqiang and Parwani, Anil and Li, Zaibo},
title = {Update on HER2 Testing in Breast Cancer: HER2-ultralow, HER2-low, HER2-null Clinical Categories and Challenges in HER2 Assessment},
journal = {Journal of Clinical and Translational Pathology},
year = {2026},
doi = {10.14218/jctp.2026.00040}
}
EUVIMED